Hepatic resection
Hepatic resection is a medical procedure with 18 clinical trials. Currently 1 active trials ongoing. Historical success rate of 71.4%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
1
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC
Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases
HR Versus RFA for HCC in Patients With PHT
A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion
HR Versus RFA for Early Stage HCC
Clinical Trials (18)
The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC
Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases
HR Versus RFA for HCC in Patients With PHT
A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion
HR Versus RFA for Early Stage HCC
Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC)
Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria
Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor
R1vascular Hepatectomy for HCC Patients
Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma
Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases
A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma
Bile Leak After Liver Surgery
Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy
Resection for Multiple Hepatocellular Carcinomas (HCC)
Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm
Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis
Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers
All 18 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 18